Kazuhiro Motoki

4.9k total citations · 1 hit paper
41 papers, 4.2k citations indexed

About

Kazuhiro Motoki is a scholar working on Molecular Biology, Immunology and Organic Chemistry. According to data from OpenAlex, Kazuhiro Motoki has authored 41 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 22 papers in Immunology and 8 papers in Organic Chemistry. Recurrent topics in Kazuhiro Motoki's work include Immune Cell Function and Interaction (12 papers), Glycosylation and Glycoproteins Research (8 papers) and Carbohydrate Chemistry and Synthesis (7 papers). Kazuhiro Motoki is often cited by papers focused on Immune Cell Function and Interaction (12 papers), Glycosylation and Glycoproteins Research (8 papers) and Carbohydrate Chemistry and Synthesis (7 papers). Kazuhiro Motoki collaborates with scholars based in Japan, United States and Russia. Kazuhiro Motoki's co-authors include Yasuhiko Koezuka, Ryusuke Nakagawa, Hitomi Ueno, Junqing Cui, Hiroshi Sato, Tetsu Kawano, Isao Toura, Yoshikatsu Kaneko, Eisuke Kondo and Haruhiko Koseki and has published in prestigious journals such as Science, Blood and Nature Biotechnology.

In The Last Decade

Kazuhiro Motoki

40 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CD1d-Restricted and TCR-Mediated Activation of V _α 14 NKT Cells by Glycosylceramides

1997 2.1k citations Yasuhiko Koezuka, Kazuhiro Motoki et al. profile →

Peers

Countries citing papers authored by Kazuhiro Motoki

Since Specialization

Citations

This map shows the geographic impact of Kazuhiro Motoki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazuhiro Motoki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazuhiro Motoki more than expected).

Fields of papers citing papers by Kazuhiro Motoki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kazuhiro Motoki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazuhiro Motoki. The network helps show where Kazuhiro Motoki may publish in the future.

Co-authorship network of co-authors of Kazuhiro Motoki

This figure shows the co-authorship network connecting the top 25 collaborators of Kazuhiro Motoki. A scholar is included among the top collaborators of Kazuhiro Motoki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kazuhiro Motoki. Kazuhiro Motoki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Targeting tead/yap-transcription-dependent necrosis, triad, ameliorates Huntington’s disease pathology 2017 ·Journal of the Neurological Sciences ·(unknown), Yu Mao, Mengting Xu, (unknown), Kazuhiro Motoki, T Sasabe, Hidenori Homma, Kazuhiko Tagawa, Tomohiro Tamura, Hitoshi Okazawa	14
2	TRAIL-R2 Superoligomerization Induced by Human Monoclonal Agonistic Antibody KMTR2 2015 ·Scientific Reports ·Taro Tamada, Daisuke Shinmi, Masahiro Ikeda, (unknown), Shiro Kataoka, Ryota Kuroki, (unknown), Kazuhiro Motoki	25
3	Antibody expression in protease-deficient strains of the methylotrophic yeastOgataea minuta 2007 ·FEMS Yeast Research ·(unknown), Yoshinori Kitagawa, Kazuo Kobayashi, Haruhiko Tsumura, Toshihiro Komeda, (unknown), Kazuhiro Motoki, (unknown), Yasunori Chiba, Yoshifumi Jigami	26
4	Switching constant domains enhances agonist activities of antibodies to a thrombopoietin receptor 2007 ·Nature Biotechnology ·Masayuki Kai, Kazuhiro Motoki, Hideaki Yoshida, (unknown), (unknown), (unknown), (unknown), (unknown), Munetake Shimabe, (unknown), Tetsuya Hagiwara, Atsushi Matsumoto, Hiroshi Miyazaki, Shiro Kataoka	23
5	Distinct function of monoclonal antibody to TRAIL‐R2 as potentiator or inhibitor of the ligand TRAIL‐induced apoptosis 2005 ·FEBS Letters ·(unknown), (unknown), Kazuhiro Motoki, Shiro Kataoka	2
6	Essential Role of Bystander Cytotoxic CD122+CD8+ T Cells for the Antitumor Immunity Induced in the Liver of Mice by α-Galactosylceramide 2004 ·The Journal of Immunology ·Ryusuke Nakagawa, Takuo Inui, (unknown), (unknown), Kazuhiro Motoki, Akira Yamauchi, Mitsuomi Hirashima, Yoshiko Habu, Hiroyuki Nakashima, Shuhji Seki	34
7	Human normal hepatocytes are susceptible to apoptosis signal mediated by both TRAIL-R1 and TRAIL-R2 2003 ·Cell Death and Differentiation ·(unknown), (unknown), Kazuhiro Motoki, (unknown), (unknown), Kazuma Tomizuka, I. Ishida, S. Kataoka	69
8	Age-Associated Augmentation of the Synthetic Ligand- Mediated Function of Mouse NK1.1 Ag+ T Cells: Their Cytokine Production and Hepatotoxicity In Vivo and In Vitro 2002 ·The Journal of Immunology ·Takuo Inui, Ryusuke Nakagawa, (unknown), Yoshiko Habu, Yuji Koike, Kazuhiro Motoki, Noritsugu Kuranaga, Masashi Fukasawa, Nariyoshi Shinomiya, Shuhji Seki	52
9	Activation of natural killer T cells by α-galactosylceramide in the presence of CD1d provides protection against colitis in mice 2000 ·Gastroenterology ·Lawrence J. Saubermann, Paul L. Beck, Ype P. de Jong, Richard S. Pitman, Mark Ryan, Hyun S. Kim, Scott B. Snapper, Susan J. Hagen, Osamu Kanauchi, Kazuhiro Motoki, Teruyuki Sakai, Cox Terhorst, Yasuhiko Koezuka, Daniel K. Podolsky, Richard S. Blumberg, Mark A. Exley, Steven P. Balk	175
10	Development of KRN7000, derived from agelasphin produced by Okinawan sponge 1997 ·Folia Pharmacologica Japonica ·Takenori Natori, (unknown), Kazuhiro Motoki, Yasuhiko Koezuka, Tatsuo Higa	17
11	Immunostimulatory activities of mono- or diglycosylated α-galactosylceramides 1997 ·Bioorganic & Medicinal Chemistry ·(unknown), Toshiyuki Shimizu, (unknown), Hitomi Ueno, Kazuhiro Motoki, Hideaki Fukushima, Takenori Natori, Yasuhiko Koezuka	17
12	Enhancing effects of α-, β-monoglycosylceramides on natural killer cell activity 1996 ·Bioorganic & Medicinal Chemistry ·Eiichi Kobayashi, Kazuhiro Motoki, Yasunori Yamaguchi, Takeshi Uchida, Hideaki Fukushima, Yasuhiko Koezuka	55
13	Effects of .ALPHA.-Galactosylceramides on Bone Marrow Cells in Vitro and Hematopoiesis in Vivo. 1996 ·Biological and Pharmaceutical Bulletin ·Kazuhiro Motoki, Masahiro Morita, Eiichi Kobayashi, Takeshi Uchida, Hideaki Fukushima, Yasuhiko Koezuka	2
14	Granulocyte-colony stimulating factor and stem cell factor are the crucial factors in long-term culture of human primitive hematopoietic cells supported by a murine stromal cell line. 1996 ·PubMed ·Nobusuke Nishi, Rei Ishikawa, H. Inoue, Masanobu Nishikawa, Minoru Kakeda, (unknown), Haruhiko Tsumura, Hiroshi Ohashi, Yuki Yamaguchi, Kazuhiro Motoki, T Sudo, (unknown)	18
15	Enhancing Effects of Agelasphin-11 on Natural Killer Cell Activities of Normal and Tumor-Bearing Mice. 1996 ·Biological and Pharmaceutical Bulletin ·Eiichi Kobayashi, Kazuhiro Motoki, Takenori Natori, Takeshi Uchida, Hideaki Fukushima, Yasuhiko Koezuka	11
16	Immunostimulatory and Antitumor Activities of Monoglycosylceramides Having Various Sugar Moieties. 1995 ·Biological and Pharmaceutical Bulletin ·Kazuhiro Motoki, Masahiro Morita, Eizaburo Kobayashi, Takeshi Uchida, K. Akimoto, (unknown), Yasuhiko Koezuka	45
17	Structure-Activity Relationship of .alpha.-Galactosylceramides against B16-Bearing Mice 1995 ·Journal of Medicinal Chemistry ·Masahiro Morita, Kazuhiro Motoki, Kohji Akimoto, Takenori Natori, Teruyuki Sakai, Eiji Sawa, Kazuo Yamaji, Yasuhiko Koezuka, Eiichi Kobayashi, Hideaki Fukushima	490
18	Structural Diversity of Mammalian Hepatic Dermatan Sulfates. 1993 ·Biological and Pharmaceutical Bulletin ·Ichiro Koshiishi, Kazuhiro Motoki, (unknown), Toshio Imanari	5
19	Vasorelaxant mechanism of KRN2391 and nicorandil in porcine coronary arteries of different sizes 1993 ·British Journal of Pharmacology ·Atsushi Miwa, (unknown), Kazuhiro Motoki, (unknown), (unknown), Yuji Okada, Hideaki Fukushima, Nobuyuki Ogawa	13
20	Determination of human urinary hyaluronic acid, chondroitin sulphate and dermatan sulphate as their unsaturated disaccharides by high-performance liquid chromatography 1991 ·Journal of Chromatography B Biomedical Sciences and Applications ·Hidenao Toyoda, Kazuhiro Motoki, (unknown), Kazufusa Shinomiya, Hiroshi Akiyama, Toshio Imanari	50

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact